Phase 1 biotech developing novel therapies for cystic fibrosis.
Industry: Health Care
Latest Trade: $20.03 0.00 (0.0%)
First Day Return: +38.9%
Return from IPO: +11.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/17/2025 |
Offer Price | $18.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 10.6 |
Deal Size ($mm) | $191 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/06/2025 |
Offer Price | $18.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 10.6 |
Deal Size ($mm) | $191 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Goldman Sachs |
TD Cowen |
more |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2019 |
Employees at IPO | 35 |
Website www.sionnatx.com |